Increase first cycle pregnancy rate
Cut costs or welcome more patients for increased revenue
Save administrative and embryo evaluation time
Connect to our secure digital platform, EMBRYOLY, to evaluate the embryonic development in context of each patient’s unique clinical characteristics.
EMBRYOLY is directly connected to your time-lapse microscope (MIRI®, GERI®, EMBRYOSCOPE®, EMBRYOSCOPE+®) and uses artificial intelligence to personalize, support and shorten your decision-making.
EMBRYOLY also automates the management of select administrative tasks.
>4 500 cycles
evaluated by EMBRYOLY
>22 000 embryos
ranked using EMBRYOLY
>1 500 patients
connected to EMBRYOLY
We are a research-backed company. ImVitro held oral presentations at ESHRE in 2022 & 2024 with another to come at ASRM. You can also read our peer-reviewed articles published in Human Reproduction and Reproductive BioMedicine Online. Our abstracts have been accepted at conferences like FFER (2023) and ASEBIR (2024).
ImVitro is an ISO 13485 certified company. EMBRYOLY obtained the CE and UKCA MARKING certification and complies with the medical device standards to provide the highest standard of safety, security, cyber-security and transparency to our partners